Steve Glover, Founder, Chairman, CHIEF EXECUTIVE OFFICER, & & Head Of State of ZyVersa Therapies, Inc. ZVSA, was just recently a visitor on Benzinga’s All-Access.
ZyVersa is a clinical-stage specialized biopharmaceutical business leveraging sophisticated exclusive innovations to establish first-in-class medications for people with inflammatory or kidney illness with high unmet clinical demands.
The business presently has 2 unique medications in the growth pipe. IC 100, an “ASC inflammasome prevention” deals with inflammatory illness. VAR200 is a “Cholesterol Efflux Arbitrator” targeting kidney illness.
Enjoy the complete meeting below:
Included picture by danilo.alvesd on Unsplash
This article consists of funded advertising and marketing web content. This web content is for informative functions just as well as is not planned to be spending guidance.
